Ok, Fast Track Designation has been given to CHM CD17 as well as to IMU's Azer-Cel and Bile Duct Cancer CF 33 applications and has done nothing to the sp. The difference her could be that RAD 101 is in its final stages before an early FDA approval and, the big difference
BIG PHARMA is interested and already got a " Poison Pill " stake of above 10% in RAD. 19.99% will be coming very soon, big question is whether they leave it that way to avoid ASIC or if they just secure 100% of RAD as there is so much more already in the pipeline that got " First in class / Best in class " status ".
And we all agree, Lantheus got it already cheap for 6c, how in the world can this trade at 2.4c???????????????????
RAD Price at posting:
2.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)